Rocket Pharmaceuticals (RCKT) PT Raised to $15 at Cantor Fitzgerald
Tweet
Share
E-mailGet Alerts RCKT Hot Sheet
Price: $3.35 +6.01%
Rating Summary:
15 Buy, 7 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Rating Summary:
15 Buy, 7 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Join SI Premium – FREE
Cantor Fitzgerald analyst Josh Schimmer raised the price target on Rocket Pharmaceuticals (NASDAQ: RCKT) to $15.00 (from $10.00) while maintaining a Overweight rating.
You May Also Be Interested In
- CLSA Downgrades Subaru Corp. (7270:JP) (FUJHY) to Outperform (2)
- Burckhardt Compression (BCHN:SW) PT Lowered to CHF500 at UBS
- Colruyt SA (COLR:BB) (CUYTF) PT Lowered to EUR36.50 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
